Targeted cancer therapy with tyrosine kinase inhibitors

Synonyms Tyrosine kinase inhibitors include : imatinib, sunitinib, midostaurine and many others Introduction Tyrosine kinase inhibitors are also known as tyrosine kinase inhibitors. This is a group of drugs that inhibit the enzyme tyrosine kinase, which is involved in the development, survival and spread of cancer in the body. Tyrosine kinase inhibitors, such as the … Targeted cancer therapy with tyrosine kinase inhibitors

Side effects | Targeted cancer therapy with tyrosine kinase inhibitors

Side effects Tyroin kinase inhibitors are highly potent drugs. Their use can lead to side effects that do not necessarily occur in every patient. In some cases, these can be serious to life-threatening, which is why a doctor should be consulted immediately. In general, treatment with tyrosine kinase inhibitors requires close monitoring of symptoms and … Side effects | Targeted cancer therapy with tyrosine kinase inhibitors

Interaction | Targeted cancer therapy with tyrosine kinase inhibitors

Interaction Tyrosine kinase inhibitors, like many other drugs, are metabolised and broken down by certain enzymes in the liver. Thus, many drugs can influence the effect of tyrosine kinase inhibitors, but tyrosine kinase inhibitors can also influence other drugs. The effect can be enhanced, which is associated with an increased risk of side effects; or … Interaction | Targeted cancer therapy with tyrosine kinase inhibitors

Price | Targeted cancer therapy with tyrosine kinase inhibitors

Price Tyrosine kinase inhibitors are active ingredients from the group of genetically engineered monoclonal antibodies. This newer, targeted treatment of cancer is still very expensive. As a rule, it is a long-term or even life-long therapy to suppress a relapse. Glivec (contains the active ingredient Imatinib) in the therapy of chronic myeloid leukemia costs over … Price | Targeted cancer therapy with tyrosine kinase inhibitors